SCHEMBL2950669

SCHEMBL2950669

COC(=O)C1CCC(N(CCNC(=O)OC(C)(C)C)C(=O)CCl)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 1/20 0.40
TSHR P16473 1/20 0.40
EPHX1 P07099 1/20 0.39
TDP1 Q9NUW8 1/20 0.36
REN P00797 1/20 0.35
GAA P10253 1/20 0.35
PIN1 Q13526 1/20 0.34
DRD2 P14416 5/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CKS1B P61024 1/20 0.31
SKP1 P63208 1/20 0.31
SKP2 Q13309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2950667 1.00 KMT2A (0.40) KMT2AMEN1ALDH1A1TSHREPHX1
SCHEMBL12524368 0.83 EPHX1 (0.40) KMT2AMEN1ALDH1A1TSHREPHX1
SCHEMBL5619020 0.80 EPHX1 (0.44) KMT2AMEN1ALDH1A1TSHREPHX1
SCHEMBL2599903 0.79 GAA (0.35) ALDH1A1GAAPIN1SMN1; SMN2
SCHEMBL20285073 0.75 PIN1 (0.42) KMT2AMEN1ALDH1A1TSHREPHX1
SCHEMBL14334774 0.74 TDP1 (0.42) KMT2AMEN1ALDH1A1TSHREPHX1
SCHEMBL27163404 0.74 EPHX1 (0.46) KMT2AMEN1ALDH1A1TSHREPHX1
SCHEMBL2390476 0.73 CKS1B (0.35) EPHX1RENDRD2CKS1BSKP1
SCHEMBL2390478 0.73 CKS1B (0.35) EPHX1RENDRD2CKS1BSKP1
SCHEMBL2951842 0.73 EPHX1 (0.51) KMT2AMEN1ALDH1A1TSHREPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7737161-B2 Condensed furan compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-06-15 US disclosed
US-20090156803-A1 Condensed furan compounds KAWAGUCHI TAKAYUKI 2009-06-18 US disclosed
US-7514449-B2 Fused furan compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-04-07 US disclosed
US-20060094724-A1 Fused furan compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2006-05-04 US disclosed
EP-1582521-A1 FUSED FURAN COMPOUND TANABE SEIYAKU CO., LTD. (JP) 2005-10-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156803-A1 Condensed furan compounds F2, F12, F11 KMT2A 2033/4885MEN1 1453/4885ALDH1A1 1627/4885
US-20060094724-A1 Fused furan compound F2, F12, F11 KMT2A 1957/4885MEN1 1870/4885ALDH1A1 1674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.